Pain Relief by Platelet-rich Plasma (PRP) Treatment
1 other identifier
observational
25
0 countries
N/A
Brief Summary
Past PRP therapy is not sufficient for some part of patients.In this clinical research, The integrated application of PRP with extracellurar matrix and some type of stem cell technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Dec 2012
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 11, 2012
CompletedFirst Posted
Study publicly available on registry
December 17, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2014
CompletedDecember 17, 2012
December 1, 2012
1 year
December 11, 2012
December 12, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
The Changes of Amounts of Pain Killer Consumed for Scheduled Term Before and After PRP treatment.
1 month
Eligibility Criteria
Athlete community
You may qualify if:
- Injury by professional sports and non professional sports
You may not qualify if:
- Other basic disease holder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 11, 2012
First Posted
December 17, 2012
Study Start
December 1, 2012
Primary Completion
December 1, 2013
Study Completion
December 1, 2014
Last Updated
December 17, 2012
Record last verified: 2012-12